JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas –
Brooke Army Medical Center doctors are working with the Southwest Texas Regional Advisory Council to help COVID patients receive the monoclonal antibody treatment and potentially lessen the severity of the illness.
Some early evidence suggests monoclonal antibody treatment can reduce the amount of the SARS-CoV-2 virus, the virus that causes COVID-19, in a person's system. This means the patient may have milder symptoms thereby decreasing the likelihood of being hospitalized.
“The goal of this treatment is to halt the progression of COVID, and to hopefully prevent inpatient admission,” said Air Force Maj. (Dr.) Joseph Yabes Jr., infectious disease physician. “Overall, people have had good responses to this therapy.”